Notal Vision has initiated the first U.S. clinical study of its patient-operated OCT system that can be used at home to monitor wet age-related macular degeneration, the company announced in a press release.
Patients with visual acuity as low as 20/400 are being enrolled in the trial at Elman Retina Group in Baltimore.
“Early user experience results indicate that elderly patients with advanced AMD and reduced visual acuity can effectively self-operate the Notal Home OCT with minimal training,” Michael J. Elman, MD, the study’s principal investigator, said in the release.
The
Uncategorized